Effect of Use of DryNites Absorbent Pants on the Rate of Spontaneous Resolution of Paediatric Nocturnal Enuresis (NE)
1 other identifier
interventional
105
1 country
2
Brief Summary
Children vary in the age at which they achieve night-time dryness; in almost all cases children will stop bed-wetting without any need for treatment. Use of absorbent pants for the management of nocturnal enuresis is controversial regarding the impact on the speed at which children become dry throughout the night. The aim of this study is to determine the effect of using DryNites absorbent pants in children with monosymptomatic nocturnal enuresis on the speed they become dry throughout the night compared with removing absorbent pants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2020
CompletedFirst Submitted
Initial submission to the registry
September 23, 2020
CompletedFirst Posted
Study publicly available on registry
November 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2023
CompletedResults Posted
Study results publicly available
December 6, 2024
CompletedDecember 6, 2024
October 1, 2024
2.9 years
September 23, 2020
December 26, 2023
October 21, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Wet Nights
Average number of wet nights
Last week of the 4-week intervention period
Secondary Outcomes (4)
Impact of Urinary Incontinence on Emotional Wellbeing of Child as Assessed by Paediatric Incontinence Questionnaire (PinQ)
Assessment will be done at each study clinic visit (Day 56 +/- 7)
Impact of Child Nighttime Enuresis on Parent/Carer Quality of Life as Assessed by the WHOQoL-BREF Questionnaire
Assessment will be done at each study clinic visit (Day 56 +/- 7)
Child Daytime Sleepiness as Assessed by PDSS Questionnaire
Assessment will be done at each study clinic visit (Day 56 +/- 7)
Parent/Carer Fatigue as Assessed by Checklist Individual Strength (CIS Questionnaire)
Assessment will be done at each study clinic visit (Day 56 +/- 7 )
Study Arms (2)
DryNites arm
EXPERIMENTALParticipants in this arm use DryNites every night for 4 weeks ("run-in" period), an additional 4 weeks (intervention "core trial" period), and an optional additional 4 weeks ("extension" period). All participants in this arm also receive absorbent bad mats to use every night.
No Pants arm
NO INTERVENTIONParticipants in this arm use DryNites every night for 4 weeks only during the initial "run-in" period. Thereafter, participants in this arm do not use DryNites during the 4 week intervention "core trial" period or the optional additional 4 weeks "extension" period. All participants in this arm also receive absorbent bad mats to use every night.
Interventions
DryNites Pyjama Pants are disposable, absorbent youth pants designed to help children manage bed wetting by absorbing involuntary urine loss and protecting the child's garments and bedding. DryNites Pyjama Pants are underwear-like alternatives that can be discreetly worn beneath pyjamas or nightwear during the bedwetting phase.
Eligibility Criteria
You may qualify if:
- Patient aged between 4-8 years at the time of enrollment
- Have a clinical diagnosis of monosymptomatic primary NE
- Have been dry in the day for \>/= 6 months prior to enrollment
- Have on average no more than 1 dry night per month during the past 6 months at enrollment
- Have an informed consent signed by the their parent(s)/carer(s)
You may not qualify if:
- Children in foster/court care
- Have implemented any previous intervention to address NE (use of prescribed alarm schedule, desmopressin, imipramine, anticholinergics) or withdrawal of pants/nappies for \> 7 days in the previous 6 months
- Have secondary NE
- Have wetting in the day
- Have faecal soiling
- Have known urinary tract disease
- Have diabetes
- Receive any regular intake of medication
- Have a known developmental/neurological disorder
- Have links to Kimberly-Clark of any kind (including family relations employed by Kimberly-Clark, holding stocks or share in Kimberly-Clark)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Mounts Bay Medical
Connor, Haley, TR27 5DT, United Kingdom
Siddarth Marnekar
Hull, HU12 8JD, United Kingdom
Related Publications (1)
Breinbjerg A, Kamperis K, Thorsteinsson K, Jorgensen CS, Dossche L, Rayner J, Zhang J, Rodrigues DG, Borch L, Hagstrom S, Tekgul S, Walle JV, Rittig S. Discontinuing absorbent pants in children with bedwetting: a randomized controlled trial. Eur J Pediatr. 2024 May;183(5):2443-2453. doi: 10.1007/s00431-024-05502-w. Epub 2024 Mar 12.
PMID: 38472381DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Science Manager
- Organization
- kimberlyClark
Study Officials
- PRINCIPAL INVESTIGATOR
Søren Riting
Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2020
First Posted
November 9, 2020
Study Start
February 21, 2020
Primary Completion
January 28, 2023
Study Completion
June 28, 2023
Last Updated
December 6, 2024
Results First Posted
December 6, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share